Published: 24-09-2024
Review
WASOG 2023 conference highlights
Abstract 150 | PDF Downloads 113Page e2024046
Inhaled budesonide and pulmonary sarcoidosis revisited
Abstract 201 | PDF Downloads 142Page e2024037
Echocardiographic evaluation of left ventricular mechanics in sarcoidosis patients without overt heart disease: a systematic review and meta-analysis
Abstract 166 | PDF Downloads 124Page e2024042
Original Articles: Clinical Research
Scar sarcoidosis: Clinical features and prognostic significance
Abstract 167 | PDF Downloads 113Page e2024046
Central Nervous System Sarcoidosis: A National-Based registry study
Abstract 179 | PDF Downloads 133Page e2024040
Hydroxychloroquine monotherapy in sarcoidosis: Indications, efficacy, and side effects
Abstract 225 | PDF Downloads 152Page e2024039
Are the gains from pulmonary rehabilitation the same in idiopathic pulmonary fibrosis and other interstitial lung diseases?
Abstract 251 | PDF Downloads 249Page e2024038
Interstitial Lung Disease in Primary Sjögren’s Syndrome: Risk factors for occurrence and radiographic progression
Abstract 232 | PDF Downloads 194Page e2024035
The management of Familial Pulmonary Fibrosis in different medical settings: Where does that leave us? An Italian nationwide survey
Abstract 240 | PDF Downloads 162Page e2024047
Assessment of quality of life in IPF Patients: a multicenter observational study
Abstract 186 | PDF Downloads 136Page e2024043
Original Articles: Laboratory Research
Schisandrin B attenuates bleomycin-induced pulmonary fibrosis in mice through AKT-mTOR pathway
Abstract 162 | PDF Downloads 122Page e2024034
Case Reports
Case of familial interstitial lung disease attributed to ATP-binding cassette transporter 3 gene mutation in identical twins
Abstract 150 | PDF Downloads 178Page e2024033
Letter to Editor
The fissural involvement in pleuroparenchymal fibroelastosis: Something beyond the alveolar elastosis
Abstract 116 | PDF Downloads 91Page e2024041